A Study of AL102 in Patients With Progressing Desmoid Tumors

Trial ID or NCT#

NCT04871282

Status

recruiting iconRECRUITING

Purpose

The current study is designed to evaluate the efficacy and safety of AL102 in patients with progressive desmoid tumors.

Official Title

RINGSIDE: A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients With Progressing Desmoid Tumors

Eligibility Criteria

Ages Eligible for Study: Older than 12 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

Nam Quoc Bui
Medical oncologist, Sarcoma specialist
Clinical Assistant Professor, Medicine - Oncology

Contact us to find out if this trial is right for you.

Contact

Ileana Aguilar Torres
ileanaa@stanford.edu

SEND MESSAGE

View on ClinicalTrials.gov